Cargando…
Metronidazole for the treatment ofTritrichomonas foetusin bulls
BACKGROUND: Tritrichomonas foetus is a sexually transmitted protozoon that causes reproductive failure, among cattle, so disruptive that many western US states have initiated control programs. Current control programs are based on the testing and exclusion of individual bulls. Unfortunately, these p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391598/ https://www.ncbi.nlm.nih.gov/pubmed/28410582 http://dx.doi.org/10.1186/s12917-017-0999-2 |
_version_ | 1783229307012775936 |
---|---|
author | Love, David Fajt, Virginia R. Hairgrove, Thomas Jones, Meredyth Thompson, James A. |
author_facet | Love, David Fajt, Virginia R. Hairgrove, Thomas Jones, Meredyth Thompson, James A. |
author_sort | Love, David |
collection | PubMed |
description | BACKGROUND: Tritrichomonas foetus is a sexually transmitted protozoon that causes reproductive failure, among cattle, so disruptive that many western US states have initiated control programs. Current control programs are based on the testing and exclusion of individual bulls. Unfortunately, these programs are utilizing screening tests that are lacking in sensitivity. Blanket treatment of all the exposed bulls and adequate sexual rest for the exposed cows could provide a more viable disease control option. The objectives of this study were twofold. The first objective was to demonstrate effectiveness for metronidazole treatment of a bull under ideal conditions and with an optimized treatment regime. This type of study with a single subject is often referred to as an n-of-1 or single subject clinical trial. The second objective of the current study was to review the scientific basis for the banning of metronidazole for use in Food Animals by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA). RESULTS: Results from an antimicrobial assay indicated that metronidazole at a concentration of 0.5 μg/mL successfully eliminated in vitro protozoal growth of bovine Tritrichomonas foetus. The estimated effective intravenous dose was two treatments with 60 mg/kg metronidazole, 24 h apart. A bull that had tested positive for Tritrichomonas foetus culture at weekly intervals for 5 weeks prior to treatment was negative for Tritrichomonas foetus culture at weekly intervals for five consecutive weeks following this treatment regimen. An objective evaluation of the published evidence on the potential public health significance of using metronidazole to treat Tritrichomonas foetus in bulls provides encouragement for veterinarians and regulators to consider approaches that might lead to permitting the legal use of metronidazole in bulls. CONCLUSION: The study demonstrated successful inhibition of Tritrichomonas foetus both in vitro and in vivo with metronidazole. The current status of metronidazole is that the Animal Medicinal Drug Use Clarification Act of 1994 prohibits its extra-label use in food-producing animals. Veterinarians and regulators should consider approaches that might lead to permitting the legal use of metronidazole in bulls. |
format | Online Article Text |
id | pubmed-5391598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53915982017-04-17 Metronidazole for the treatment ofTritrichomonas foetusin bulls Love, David Fajt, Virginia R. Hairgrove, Thomas Jones, Meredyth Thompson, James A. BMC Vet Res Research Article BACKGROUND: Tritrichomonas foetus is a sexually transmitted protozoon that causes reproductive failure, among cattle, so disruptive that many western US states have initiated control programs. Current control programs are based on the testing and exclusion of individual bulls. Unfortunately, these programs are utilizing screening tests that are lacking in sensitivity. Blanket treatment of all the exposed bulls and adequate sexual rest for the exposed cows could provide a more viable disease control option. The objectives of this study were twofold. The first objective was to demonstrate effectiveness for metronidazole treatment of a bull under ideal conditions and with an optimized treatment regime. This type of study with a single subject is often referred to as an n-of-1 or single subject clinical trial. The second objective of the current study was to review the scientific basis for the banning of metronidazole for use in Food Animals by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA). RESULTS: Results from an antimicrobial assay indicated that metronidazole at a concentration of 0.5 μg/mL successfully eliminated in vitro protozoal growth of bovine Tritrichomonas foetus. The estimated effective intravenous dose was two treatments with 60 mg/kg metronidazole, 24 h apart. A bull that had tested positive for Tritrichomonas foetus culture at weekly intervals for 5 weeks prior to treatment was negative for Tritrichomonas foetus culture at weekly intervals for five consecutive weeks following this treatment regimen. An objective evaluation of the published evidence on the potential public health significance of using metronidazole to treat Tritrichomonas foetus in bulls provides encouragement for veterinarians and regulators to consider approaches that might lead to permitting the legal use of metronidazole in bulls. CONCLUSION: The study demonstrated successful inhibition of Tritrichomonas foetus both in vitro and in vivo with metronidazole. The current status of metronidazole is that the Animal Medicinal Drug Use Clarification Act of 1994 prohibits its extra-label use in food-producing animals. Veterinarians and regulators should consider approaches that might lead to permitting the legal use of metronidazole in bulls. BioMed Central 2017-04-14 /pmc/articles/PMC5391598/ /pubmed/28410582 http://dx.doi.org/10.1186/s12917-017-0999-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Love, David Fajt, Virginia R. Hairgrove, Thomas Jones, Meredyth Thompson, James A. Metronidazole for the treatment ofTritrichomonas foetusin bulls |
title | Metronidazole for the treatment ofTritrichomonas foetusin bulls |
title_full | Metronidazole for the treatment ofTritrichomonas foetusin bulls |
title_fullStr | Metronidazole for the treatment ofTritrichomonas foetusin bulls |
title_full_unstemmed | Metronidazole for the treatment ofTritrichomonas foetusin bulls |
title_short | Metronidazole for the treatment ofTritrichomonas foetusin bulls |
title_sort | metronidazole for the treatment oftritrichomonas foetusin bulls |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391598/ https://www.ncbi.nlm.nih.gov/pubmed/28410582 http://dx.doi.org/10.1186/s12917-017-0999-2 |
work_keys_str_mv | AT lovedavid metronidazoleforthetreatmentoftritrichomonasfoetusinbulls AT fajtvirginiar metronidazoleforthetreatmentoftritrichomonasfoetusinbulls AT hairgrovethomas metronidazoleforthetreatmentoftritrichomonasfoetusinbulls AT jonesmeredyth metronidazoleforthetreatmentoftritrichomonasfoetusinbulls AT thompsonjamesa metronidazoleforthetreatmentoftritrichomonasfoetusinbulls |